KENLOR H. PYLORI CONTROL SERUM
Device Facts
| Record ID | K964014 |
|---|---|
| Device Name | KENLOR H. PYLORI CONTROL SERUM |
| Applicant | Kenlor Industries, Inc. |
| Product Code | LYR · Microbiology |
| Decision Date | Mar 3, 1997 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 866.3110 |
| Device Class | Class 1 |
Indications for Use
KENLOR H. pylori Serum Control is designed to provide unassayed precision control reagents. The controls are to be used with the in vitro immunoassay procedures for the qualitative determination of Helicobacter pylori IgG antibody in human serum assays. The controls are designed for routine use to provide a means of estimating precision and monitoring system performance. The controls are not intended to replace reagent controls furnished with the commercial kits. The control should be used like a patient sample to assist in the assessment of the listed analytical procedures.
Device Story
Liquid, ready-to-use, stabilized serum control containing human serum and protein fractions; preserved with 0.05% sodium azide. Used in clinical laboratories to monitor performance of H. pylori IgG antibody immunoassay test kits. Operates as a surrogate patient sample; processed alongside clinical specimens to assess analytical precision and accuracy. Provides healthcare providers with a means to verify system stability and assay reliability. Benefits patient care by ensuring consistent, accurate diagnostic results for H. pylori infection.
Clinical Evidence
Bench testing only. Stability studies conducted on 24 vials per lot. Closed vial stability validated for one year at 2-8°C; accelerated shelf-life study at 37°C for two months supports a two-year shelf life. Opened vial stability validated for 60 days at 2-8°C. Assigned values derived from mean assay results; target ranges established at 2x Standard Deviation.
Technological Characteristics
Stabilized liquid serum control; human serum and protein fractions; 0.05% sodium azide preservative. Form factor: liquid in vials. Storage: 2-8°C. No electronic, software, or energy-based components.
Indications for Use
Indicated for use as an unassayed precision control reagent for in vitro immunoassay procedures qualitatively determining Helicobacter pylori IgG antibodies in human serum. Intended for routine laboratory use to monitor system performance and estimate precision.
Regulatory Classification
Identification
Campylobacter fetus serological reagents are devices that consist of antisera conjugated with a fluorescent dye used to identify Campylobacter fetus from clinical specimens or cultured isolates derived from clinical specimens. The identification aids in the diagnosis of diseases caused by this bacterium and provides epidemiological information on these diseases. Campylobacter fetus is a frequent cause of abortion in sheep and cattle and is sometimes responsible for endocarditis (inflammation of certain membranes of the heart) and enteritis (inflammation of the intestines) in humans.
Predicate Devices
- Commercial Serum Controls for H. pylori Antibody (BioAmerica)
- Commercial Serum Controls for H. pylori Antibody (Elias corporation)
Related Devices
- K972146 — QUALITROL UNASSAYED H. PYLORI CONTROL SET POSITIVE AND NEGATIVE CONTROLS · Consolidated Technologies, Inc. · Jul 8, 1997
- K992550 — LIQUICHEK IMMUNOLOGY CONTROL LEVEL 1, 2, 3 · Bio-Rad · Aug 11, 1999
- K991182 — MODIFICATION OF N/T PROTEIN CONTROL SL · Dade Behring, Inc. · May 19, 1999
- K092051 — THERMO SCIENTIFIC MAS CHEM TRAK & MONI TROL H LIQUID ASSAYED CHEMISTRY CONTROL, MODEL, CHA, CHU, M5155, M5158 · Microgenics Corp. · Sep 21, 2009
- K973508 — PYLORI DETECT IGG · Micro Detect, Inc. · Mar 10, 1998